Automatic segmentation of region of interest for dry eye disease diagnosis system

Author(s):  
Ayse Arslan ◽  
Baha Sen ◽  
Fatih V. Celebi ◽  
Betul Seher Uysal
2012 ◽  
Vol 23 (4) ◽  
pp. 515-524 ◽  
Author(s):  
Mark C. Hou ◽  
Sheng-Chieh Huang ◽  
Hui-Min Wang ◽  
Cheng-Lung Tseng ◽  
Lun-Chien Lo ◽  
...  

F1000Research ◽  
2018 ◽  
Vol 7 ◽  
pp. 1952 ◽  
Author(s):  
Shruti Aggarwal ◽  
Anat Galor

Dry eye disease (DED) is a commonly encountered condition in general ophthalmology practice and imparts a significant socioeconomic burden. Despite its prevalence, there remain challenges regarding its diagnosis and management. A major reason behind these challenges is the fact that DED represents an umbrella term that encompasses many different underlying conditions and pathophysiological mechanisms. The purpose of this article is to highlight aspects of DED pathophysiology and focus on targeted diagnostic and therapeutic approaches to this multifactorial, chronic condition.


Author(s):  
Cristina Castro-Lima-Vargens ◽  
Maria Fernanda Rios Grassi ◽  
Ney Boa-Sorte ◽  
Regina Helena Rathsam-Pinheiro ◽  
Paula Caroline Matos Almeida ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-12 ◽  
Author(s):  
Suvarna P. Phadatare ◽  
Munira Momin ◽  
Premanand Nighojkar ◽  
Sonali Askarkar ◽  
Kamalinder K. Singh

Dry eye syndrome (DES) or keratoconjunctivitis sicca (KCS) is a common disorder of the tear film caused by decreased tear production or increased evaporation and manifests with a wide variety of signs and symptoms. The present review from interpretation of the literature gives detailed information on the prevalence, definition, causes, diagnostic tests, and medical management of dry eye disease. A number of systems contribute to the physiological integrity of the ocular surface and disruption of system may or may not produce symptoms. Therefore accurate diagnosis of dry eyes with no or minimal disruption of physiological function is necessary. The paper also discusses different colloidal drug delivery systems and current challenges in the development of topical ophthalmic drug delivery systems for treatment of KCS. Due to the wide prevalence and number of factors involved, newer, more sensitive diagnostic techniques and novel therapeutic agents have been developed to provide ocular delivery systems with high therapeutic efficacy. The aim of this review is to provide awareness among the patients, health care professionals, and researchers about diagnosis and treatment of KCS and recent developments and future challenges in management of dry eye disease.


Sign in / Sign up

Export Citation Format

Share Document